Categories: Awareness

Molecular Assessment Should Be Considered As A Way Of Improving Detection Of Chronic Endometritis:Igenomix

ALICE (Analysis of Infectious Chronic Endometritis), detects the most frequent bacteria that cause Chronic Endometritis.

New Delhi, September 11, 2018: Chronic Endometritis (CE) is a persistent inflammation of the endometrial lining, caused by infection of the uterine cavity, mainly by bacterial pathogens. Because it is usually asymptomatic, and current classical diagnosis methods (histology, hysteroscopy and microbial culture) are unsatisfactory, CE is often overlooked, although it affects approximately 30% of infertile women, and its prevalence in patients with RIF and Recurrent Pregnancy Loss (RPL) could reach up to 60%.

A recent study carried out by Igenomix, a company that provides advanced services in reproductive genetics has demonstrated that molecular assessment of CE is feasible, is a faster cheaper method for the diagnosis of CE as compared with the classical methods and should be considered as a way of improving detection of this often-undiagnosed endometrial pathology.

“ALICE (Analysis of Infectious Chronic Endometritis), detects the most frequent bacteria that cause CE. This expands the service offered by Igenomix, to evaluate the endometrium factor at the microbiological level, with the aim of improving the clinical management of patients with this silent disease.” Says Dr. Rajni Khajuria, Ph.D, Laboratory Manager Of IGENOMIX India.

ALICE can be beneficial for any patient wishing to conceive, by assessing the microbiological environment that the embryo will encounter at implantation. ALICE may also be beneficial for patients with a history of RPL and/or RIF, because CE has been linked to these events.

“ALICE uses the latest Next Generation Sequencing technology to provide microbiome information in endometrial tissue by analyzing the levels of specific bacteria that cause CE. The technology is based on DNA extraction followed by amplification and barcoded sequencing of the bacterial 16S ribosomal RNA gene.” further adds Dr. Rajni.

This bacterial gene, conserved in all bacteria, presents nine variable regions with species-specific DNA sequence. This enables the taxonomic assignment and relative quantification of CE bacteria present in a sample.

Furthermore, the ALICE report will focus on the detection and abundance of those specific bacteria that cause CE. These bacteria are: Enterococcus spp., Enterobacteriaceae spp., Streptococcus spp., Staphylococcus spp., Mycoplasma spp, and Ureaplasma spp. In addition, other pathogens associated with sexually transmitted infections (STI), such as Chlamydia trachomatis and Neisseria gonorrhoeae will also be reported.

“The ALICE report will recommend antibiotic therapy for the pathogens that are detected.” Says Dr. Rajni.

ALICE QUICK FACTS

  • ALICE can be performed on a small piece of endometrial biopsy.
  • If the patient is undergoing an ERA (Endometrial Receptivity Analysis) test, a small portion of the same biopsy can be used, so no additional sample will be required.
  • ALICE can be performed between days 15 and 25 of the natural cycle, or in P+5 in an HRT cycle.
  • If the patient is having an endometrial biopsy for ERA, ALICE can be analysed in the same endometrial biopsy. In this case, the sample should be taken according to recommended ERA Protocol .

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

1 day ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

1 day ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

2 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

2 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

3 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

3 days ago